Admission Date:  [**2191-10-10**]              Discharge Date:   [**2191-10-19**]  Date of Birth:  [**2106-6-1**]             Sex:   M  Service: NEUROLOGY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**Last Name (NamePattern1) 1838**] Chief Complaint: altered mental status  Major Surgical or Invasive Procedure: None   History of Present Illness: 85 y/o M w hx of CAD s/p stenting 2 months ago who presented to [**Hospital3 4107**] with "AMS".
CARDIAC HISTORY: -PERCUTANEOUS CORONARY INTERVENTIONS: -S/p cath [**2191-8-4**]: mid LAD 40% lesion with an ostial D1 40% lesion, unchanged from elective cath in [**2188**] -S/p cath [**2188**]: mid LAD 40% lesion with an ostial D1 40% lesion 3.
OTHER PAST MEDICAL HISTORY: - h/o bladder cancer, currently treated with chemo and radiation, in mid-cycle, s/p cystoscopic surgery - h/o herniated disc - s/p appendectomy - arthritis - s/p right rotator cuff surgery  Social History: -Tobacco history:  quit 28 y/a, smoked 1 ppd x 40 years -ETOH: used to drink about [**2-10**] drinks/day, stopped drinking when diagnosed with bladder cancer -Illicit drugs:  denies -ambulates independently, lives with wife who had a stroke three years ago   Family History: No family history of  MI, stroke, congestive heart failure.
He demonstrated frequent paraphasic errors and at times empty speech.
[**10-11**] NCHCT 1.
In accordance with a discussion with his primary cardiologist, his antithrombotic therapy was changed from a full-dose aspirin and clopidogrel to ASA 81, Clopidogrel 75, and a heparin infusion without bolus with goal 50-70 with the impression that the M1 occlusion was from an embolic source which later was shown to have caused bilateral embolic cerebral infarctions in multiple vascular territories on MRI.
The decision was made to keep him on dual antiplatelet therapy and anticoagulation to prevent complete occlusion of the M1 segment.
[] Intracerebral/Intracranial Hemorrhage - During the course of anticoagulation for embolic stroke, the patient was noted to have a PTT that elevated quickly from the 71.7 to 103.9 with possible suggestion of petechial hemorrhages on an NCHCT obtained to evaluate the area of completed infarction.
The Heparin drip was stopped.
His plavix and aspirin were held.
He was transferred to the ICU for further care and intubated for respiratory support and protection.
Further discussions with his HCP and family indicated that he would not want aggressive measures to be taken, and thus he was extubated and made Comfort Measures only.
Medications on Admission: 1. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
2. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) tablet Sublingual as directed.
3. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. aspirin 325 mg Tablet, Delayed Release (E.C.)
5. famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12  hours).
6. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain.
7. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain.
8. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig:  One (1) Tablet Extended Release 24 hr PO DAILY (Daily).
9. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Discharge Medications: N/A  Discharge Disposition: Home with Service  Discharge Diagnosis: Primary: Acute Ischemic Stroke, Intracerebral Hemorrhage Secondary: Ischemic Heart Disease, Cerebral Amyloid Angiopathy  Discharge Condition: Deceased  Discharge Instructions: N/A  Followup Instructions: N/A
